To this end, tumour cells were incubated with anti-PD-L1 antibody labelled with tyramide594 (energy acceptor), while aT-sEVs were incubated with anti-PD-1 or anti-CD80 antibodies labelled with AF488 (energy donor). Here, CD274 is linked to neoplasm.